YPYuri Veniaminovich Parakhin

Yuri Veniaminovich Parakhin

*This is an algorithmically generated author record based on publicly available information.

Yuri Veniaminovich Parakhin has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New import substituting technology for obtaining cell plasma therapy preparations

    by Iurii V. Parakhin, Парахин Юрий Вениаминович, German V. Neustroev, Неустроев Герман Вениаминович, Mikhail V. Parshikov, Паршиков Михаил Викторович, Nikolai V. Jarigin, Ярыгин Николай Владимирович, Tatiana G. Kuzbaseva, Кузбашева Татьяна Георгиевна, et al.

    BACKGROUND: In recent decades, autologous cellular plasma therapy (CPT) has become a promising treatment for musculoskeletal conditions due to the ability of activated blood cells to release growth factors, anti-inflammatory, and analgesic cytokines. However, the high cost of foreign consumables and equipment limits treatment accessibility. AIM: To compare a new a new Russian plasma preparation (LR-PRP) technology for musculoskeletal conditions with the foreign RegenLab (RL) technology (RegenLab technology is registered and approved; Reg. No. FSZ 2011/10571, dated December 30, 2011; Reg. No. FSZ 2011/10570, dated September 15, 2011; and Reg. No. FSZ 2011/11417, dated December 30, 2011) technology in terms of production methods, activation methods, and cellular composition of the resulting preparations. METHODS: We conducted an experimental, open-label, prospective study. Between March 2024 and May 2025, we compared the two preparations—LR-PRP and PRP (RL)—by production methods, cellular composition, and activation method. The study involved 20 patients aged 25 to 58 years with musculoskeletal conditions, from whom 10 mL of blood was drawn. CPT preparations were prepared and studied using the new Russian technology (12 patients) and the RL technology (8 patients). RESULTS: LR-PRP contains platelets, leukocytes, and erythrocytes, providing a broader range of biologically active substances than PRP (RL), which contains only platelets. Cellular composition analysis showed that the domestic technology allows controlled preparation of products with both high and low cell concentrations. Activation with calcium chloride (CaCl₂) enhances growth factor release, including red blood cell hemolysis products and microvesicles, which increases regenerative potential. Comparison showed advantages of LR-PRP: cost-effectiveness, ease of use, preservation of biologically active substances activity through low-temperature sedimentation, and avoidance of mechanical cell damage. However, further studies on dosage, activation, and effectiveness in various conditions are needed to optimize clinical use. CONCLUSIONS: Thus, the new import-substituting technology for obtaining cell plasma therapy preparations is a promising alternative to imported PRP preparations, combining availability, ease of preparation, physiological properties and a wide range of obtained biologically active substances.

  • THE PROGRAM OF REHABILITATION TREATMENT AFTER ORGAN-PRESERVING OPERATIONS FOR PATIENTS WITH ASEPTIC NECROSIS OF THE FEMORAL HEAD STAGE I-II ACCORDING TO ARCO

    by Yurii Parakhin, Парахин Юрий Вениаминович, Mikhail V. Parshikov, Паршиков Михаил Викторович, Nikolai V. Jarigin, Ярыгин Николай Владимирович, Tatiana G. Kuzbasheva, Кузбашева Татьяна Георгиевна, Mikhail V. Govorov, Говоров Михаил Владимирович, et al.

    BACKGROUND: One of the promising approaches to surgical treatment of early-stage avascular necrosis of the femoral head (ANFH) involves procedures that include tunneling and intrafocal reconstruction of the femoral head using cell-based technologies. However, a comprehensive rehabilitation program following organ-preserving surgeries has not yet been developed. AIM: To develop an integrated rehabilitation program for patients undergoing organ-preserving interventions for early-stage avascular necrosis of the femoral head, applicable to both early and late rehabilitation periods, and to assess its efficacy and safety. METHODS: A prospective, single-center, observational, randomized, controlled, single-blind clinical study was conducted to compare the effectiveness of a newly developed rehabilitation program versus standard rehabilitation after organ-preserving surgery for patients with ARCO stage I–II avascular necrosis of the femoral head. RESULTS: .The study included 59 patients aged 24 to 58 years with ARCO stage I–II ANFH. The surgical protocol was based on an original technique that combined minimally invasive multiplanar intrafocal decompressive tunneling with bone autoplasty and PRGF (Plasma Rich in Growth Factors)–mediated cell stimulation, followed by rehabilitation measures. Patients were randomly allocated into two groups: the intervention group, which received the new rehabilitation program, and the control group, which received standard rehabilitation. Clinical data were collected before treatment and at the completion of the inpatient phase of late postoperative rehabilitation. The study period was January 2020 to December 2024. Following treatment (surgery plus rehabilitation), both groups demonstrated positive outcomes. The most significant finding was the difference in the progression rate of ANFH according to MRI and radiography. At 12 months, signs of femoral head collapse were observed in 25% of joints in the intervention group compared with 32.3% in the control group. CONCLUSION: The widespread implementation of a structured rehabilitation program for both early and late recovery phases after organ-preserving surgery for ARCO stage I–II avascular necrosis of the femoral head may improve treatment outcomes and enhance overall quality of life in this patient population.

  • Key pathogenetic components of aseptic loosening of joint prostheses

    by Alexander D. Kamenskiy, Yurii V. Parakhin, Mikhail V. Parshikov, Парахин Юрий Вениаминович

    This review provides a comprehensive analysis of the pathogenetic mechanisms underlying aseptic loosening of joint prostheses and the associated periprosthetic osteolysis. Based on the systematization of current scientific evidence, the key factors contributing to the development of these complications are examined. A central focus is placed on debris-induced inflammation, in which prosthetic wear debris (metals, polyethylene, and bone cement) activates macrophages, leading to the release of pro-inflammatory cytokines (TNF-α, IL-1, IL-6). These mediators disrupt bone remodeling by stimulating osteoclastogenesis via activation of the RANKL/RANK/OPG signaling pathway and by suppressing osteoblast function. Particular attention is paid to the role of mechanical factors, including physiological implant micromotion, which, when exceeding the tolerance threshold (greater than 50–150 μm), impairs osseointegration and promotes the formation of a fibrous synovial-like interfacial membrane, as well as the phenomenon of stress shielding, resulting in bone resorption due to altered load distribution. The influence of pressurized fluid flow (up to 150 mmHg), which enhances bone destruction through direct effects on osteocytes, is also discussed. Specific immune responses to prosthetic components are analyzed in detail: the haptenic properties of metal ions (Co, Cr, Ti) and bone cement can initiate delayed-type hypersensitivity reactions with neoantigen formation and T cell activation. The local and systemic toxic effects of metallic particles are considered, including DNA damage and inhibition of osteoblast and mesenchymal stem cell proliferation. The contribution of bacterial endotoxins adsorbed onto wear particles, which can potentiate inflammation even in the absence of clinically evident infection, is highlighted. It is emphasized that aseptic loosening is a multifactorial process in which the combined action of these mechanisms shifts the balance toward osteolysis. Prospective strategies to reduce the risk of aseptic loosening include investigation of genetic susceptibility, development of biocompatible materials with improved tribological properties, and targeted suppression of inflammatory cascades. A systematic understanding of the underlying pathogenesis constitutes the basis for improving implant longevity and reducing the rate of revision interventions.

  • Open Access

    Role of Gene Polymorphisms in the Development of Aseptic Loosening of Knee and Hip Prostheses: A Review

    by Alexandr Dmitrievich Kamenskiy, Alexandra Il'Inichna Don'Kina, Yuri Veniaminovich Parakhin, Olga Grigor'Evna Kovtun, Mikhail Viktorovich Parshikov, Донькина Александра Ильинична

    Background. Aseptic loosening is a significant issue in the endoprosthetics of major joints of the lower limbs. In the modern view, aseptic loosening of joint prostheses is primarily caused by prolonged inflammation, which induces periprosthetic osteolysis. Various factors, such as sex, age, activity level, and others, can influence the development of periprosthetic osteolysis and aseptic loosening. Some researchers attribute to the factors gene polymorphisms related to inflammation, bone metabolism, and other processes. Understanding the connection between specific genetic markers and the development of endoprosthetic complications can provide deeper insights into the mechanisms of periprosthetic osteolysis and aseptic loosening, as well as allow for better prediction of complications in patients. The aim of the study — based on a literature review, to identify the role of individual genetic traits in the development of periprosthetic osteolysis and aseptic loosening of joint prostheses. Methods. The search for original studies was conducted in the PubMed, Google Scholar, and eLIBRARY databases using the following keywords: endoprosthetics, genetics, aseptic loosening, polymorphism. Relevance to the research topic was verified by titles and abstracts of the articles, followed by analysis of the full-text versions. Papers with no access to the full text were not assessed. Results. Polymorphisms in genes regulating inflammation, bone metabolism, differentiation, apoptosis, and cell division processes can influence the development of aseptic loosening. Among such genes are IL1B, IL6, RANK, OPG, FRZB, and others. Data from genome-wide association studies are contradictory and may suggest that genetic factors influencing aseptic loosening can differ among various populations. Conclusions. Individual genetic traits might play a significant role in the development of periprosthetic osteolysis and aseptic loosening of joint prostheses. Although several studies have identified genetic polymorphisms that presumably influence the development of loosening, further research is needed to verify these results and assess the possibility of extrapolating the findings to other populations.


  • Method for minimally invasive multiple tunnelization of the femoral head in case of its aseptic necrosis

    by Iurii V. Parakhin, Mikhail V. Parshikov, Vladimir V. Guryev, Nikolai V. Jarigin, Парахин Юрий Вениаминович, Nikolay V. Yarigin

    BACKGROUND: Aseptic necrosis of the femoral head (ANFH) is a serious disease that often affects young and middle-aged people (20–50 years) and accounts for up to 4.7% of degenerative-dystrophic hip disorders. In its late stages, it usually leads to destruction of the femoral head and functional failure of the hip joint as a whole due to impaired blood supply and low bone remodelling capacity. The clinical picture in the early stages of ANFH is often asymptomatic, although patients may develop groin pain that may radiate into the knee joint or ipsilateral buttock. On physical examination, patients usually have limited range of motion in the hip joint and pain on forced internal rotation. Modern diagnostic methods available include radiography, scintigraphy, functional bone assessment, computed tomography, histological studies and magnetic resonance imaging (MRI), which has recently become the most widely used by many clinicians. Early signs of osteonecrosis can only be detected by MRI, which allows the most accurate determination of the stage of the pathological process, assessment of the prevalence of the lesion, structural changes in the bone marrow, the presence of fluid in the joint, the state of the articular cartilage and other soft tissues of the hip joint. Contrast MRI shows delayed perfusion of the contrast agent in the necrosis zone. CLINICAL CASE DESCRIPTION: The article describes an original method of organ-preserving surgery — minimally invasive multiple tunneling of the femoral head with aseptic necrosis without collapse, and presents a clinical observation. The positive outcome of the surgical procedure was confirmed functionally (preservation of the range of motion of the operated joint, absence of pain syndrome) and by MRI data (preservation of the shape of the femoral head, signs of remodelling of the necrosis focus). CONCLUSION: At present, the diagnostic possibilities of detecting aseptic necrosis of the femoral head at the pre-radiological stage are becoming a routine examination due to the increasing availability of MRI in the medical and preventive facilities. With the emergence of new technological possibilities in modern medicine, minimally invasive treatment of the lesion by multiple tunnelling to improve blood circulation in combination with cellular stimulation of reparative processes with growth factors in the femoral head makes it possible to preserve the viability of the femoral head and avoid joint endoprosthesis.


  • Etiology and pathogenesis of aseptic necrosis of the femoral head in athletes

    by Moscow N.A. Semashko Railroad Clinical Hospital, Yuriy V. Parakhin, Mikhail V. Parshikov, Vladimir V. Guriev

    Aseptic necrosis of the femoral head (ANFH) is a severe, rapidly progressing disease, one of the most common types of pathology of the musculoskeletal system and occupies 1.5–4.7% of destructive-dystrophic lesions of the hip joint [1]. Most often, the pathological process develops in adults, aged 20 to 50 years; mainly young and active people are affected [2]. The highest prevalence is in men aged 20–23 years, and in women aged 23–25 [3]. In athletes, the most common cause of ANFH development is sports injuries. Particularly traumatic sports are football, hockey, rugby, equestrianism, rowing slalom, figure skating, artistic and rhythmic gymnastics. The main cause of injury in athletes is non-compliance with the training regime. Moreover, 50% of all injuries are injuries to the lower extremities, 20% of athletes have a combined injury of various types of pathology in the hip joint (HJ). A typical feature of ANFH in athletes in cases of traumatic etiology is a unilateral lesion — up to 25% of cases, and in male athletes this pathology is 5–6 times more common than in female athletes. The disease is chronic and progressive, leading to a persistent decrease in limb function. The economic burden placed on society in this regard is constantly increasing [4, 5]. Objective of the study. Analysis of accumulated knowledge in the medical literature regarding the etiology, risk factors and pathogenesis of osteonecrosis of the femoral head in athletes. Material and methods. Open data sources (eLibrary, Scopus, PubMed, etc.) were used as a scientific base to achieve the goals set. The literature search was carried out by keywords among articles in English and Russian on databases of medical publications: CyberLeninka, Google Scholar, Medline, ClinicalTrials, etc. The search depth is not limited. Literature sources devoted to orthopedic methods of treatment are excluded from the study.